Dudzińska, M.; Szczyrek, M.; Wojas-Krawczyk, K.; Świrska, J.; Chmielewska, I.; Zwolak, A.
Endocrine Adverse Events of Nivolumab in Non-Small Cell Lung Cancer Patients—Literature Review. Cancers 2020, 12, 2314.
https://doi.org/10.3390/cancers12082314
AMA Style
Dudzińska M, Szczyrek M, Wojas-Krawczyk K, Świrska J, Chmielewska I, Zwolak A.
Endocrine Adverse Events of Nivolumab in Non-Small Cell Lung Cancer Patients—Literature Review. Cancers. 2020; 12(8):2314.
https://doi.org/10.3390/cancers12082314
Chicago/Turabian Style
Dudzińska, Marta, Michał Szczyrek, Kamila Wojas-Krawczyk, Joanna Świrska, Izabela Chmielewska, and Agnieszka Zwolak.
2020. "Endocrine Adverse Events of Nivolumab in Non-Small Cell Lung Cancer Patients—Literature Review" Cancers 12, no. 8: 2314.
https://doi.org/10.3390/cancers12082314
APA Style
Dudzińska, M., Szczyrek, M., Wojas-Krawczyk, K., Świrska, J., Chmielewska, I., & Zwolak, A.
(2020). Endocrine Adverse Events of Nivolumab in Non-Small Cell Lung Cancer Patients—Literature Review. Cancers, 12(8), 2314.
https://doi.org/10.3390/cancers12082314